Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
Heart Failure
65%
Paroxysmal Atrial Fibrillation
38%
Subarachnoid Hemorrhage
30%
Heart Disease
22%
Anticoagulant Agent
20%
Thromboembolism
19%
Brain Natriuretic Peptide
19%
Prevalence
19%
Inflammation
18%
Acute Coronary Syndrome
16%
Warfarin
16%
Bleeding
16%
All Cause Mortality
16%
Acute Heart Infarction
15%
Rivaroxaban
15%
Statin (Protein)
15%
Noradrenalin
15%
Heart Failure with Reduced Ejection Fraction
15%
C Reactive Protein
14%
Heart Ventricle Tachycardia
14%
Disease
14%
Heart Arrhythmia
13%
Cardiovascular Disease
13%
Creatinine
13%
Heart Infarction
11%
Coronary Artery Disease
11%
Antivitamin K
11%
Apixaban
10%
Heart Rate Turbulence
9%
Congestive Heart Failure
9%
End Stage Renal Disease
9%
Acute Heart Failure
9%
D Dimer
9%
Heart Failure with Preserved Ejection Fraction
8%
Antiarrhythmic Agent
8%
Cardiovascular Risk
8%
Antiplatelet
7%
Central Sleep Apnea Syndrome
7%
Left Ventricular Systolic Dysfunction
7%
Acute Kidney Failure
7%
Faintness
7%
Coronavirinae
7%
Low Density Lipoprotein Cholesterol
7%
Systolic Heart Failure
7%
Edoxaban
7%
Idarucizumab
7%
Cardiac Sarcoidosis
7%
Pilsicainide
7%
Calcium Antagonist
7%
Medicine and Dentistry
Atrial Fibrillation
57%
Heart Failure
44%
Risk Stratification
27%
Sudden Cardiac Death
22%
T Wave Amplitude
20%
Heart Rate Variability
19%
Thromboembolism
18%
Prevalence
17%
Ventricular Tachycardia
16%
Pulmonary Vein Isolation
16%
Odds Ratio
15%
D-Dimer
15%
Heart Left Ventricle Ejection Fraction
15%
Acute Kidney Injury
15%
Home Monitoring
15%
Remote Sensing
15%
Percutaneous Coronary Intervention
15%
Heart Failure with Reduced Ejection Fraction
15%
Catheter Ablation
15%
Creatinine
14%
T Wave
14%
Electrocardiogram
13%
Acute Coronary Syndrome
13%
Vitamin K Antagonist
12%
Cardiac Dysrhythmia
12%
Brain Natriuretic Peptide
11%
Cardiovascular System
11%
Obstructive Sleep Apnea
11%
Antithrombotic
11%
Nonsustained Ventricular Tachycardia
11%
Logistic Regression Analysis
11%
Heart Rhythm
10%
Paroxysmal Atrial Fibrillation
10%
Apnea
10%
Apixaban
10%
Anticoagulation
9%
Ventricular Fibrillation
9%
Hazard Ratio
9%
Autonomic Function
9%
QRS Complex
9%
Chronic Kidney Disease
9%
Acute Decompensated Heart Failure
9%
Subarachnoid Hemorrhage
9%
Urinary System
8%
Persistent Atrial Fibrillation
8%
Heart Failure with Preserved Ejection Fraction
8%
Holter Monitoring
8%
Brain Ischemia
8%
Proportional Hazards Model
7%
Disease
7%
Keyphrases
Cardiac Intensive Care Unit
15%
Risk Stratification
9%
Detrended Cross-correlation Analysis
7%
Electrotonic
7%
Persistent Cycle
7%
Pacemaker Activity
7%
Bio-signal Analysis
7%
Cross-correlation Analysis
7%
Atrial muscle
7%
Small RNA Sequencing
7%
Sinoatrial Node
7%
Atrial Fibrillation Progression
7%
Savitzky-Golay
7%
Multiple Wavelet
7%
Heteroscedasticity
7%
Dose Reduction Criteria
7%
Fatty
7%
Urine Flow
7%
Right Ventricular Outflow Tract
7%
Cylindrical Model
7%
Complex Patients
7%
Premature Ventricular Complexes
7%
Entropy Characteristic
7%
Prognostic Importance
7%
Oxygen Desaturation
7%
Home Monitoring
7%
Remote Monitoring
7%
Driver Licensing
7%
Patient Perspective
7%
Office Visits
7%
Brain Natriuretic Peptide
7%
Atrial Fibrillation Detection
7%
Intracardiac Echocardiography
7%
Scattering Transform
7%
Cyclic Variation of Heart Rate
7%
Multiscale Entropy
7%
Ablation Index
7%
Image Sensor
7%
Amplitude Variability
7%
Vitamin K Antagonists
7%
Net Clinical Benefit
7%
Range Correlation
7%
In-office
7%
Remote Follow-up
7%
Home Study
7%
In-clinic
7%
Remote Management
7%
Edoxaban
7%
Electrophysiological Techniques
7%
Electrical Event
7%